These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND CTCF, P49711, 10664, ENSG00000102974 AND Treatment
24 results:

  • 1. An alternative NURF complex sustains acute myeloid leukemia by regulating the accessibility of insulator regions.
    Radzisheuskaya A; Peña-Rømer I; Lorenzini E; Koche R; Zhan Y; Shliaha PV; Cooper AJ; Fan Z; Shlyueva D; Johansen JV; Hendrickson RC; Helin K
    EMBO J; 2023 Dec; 42(24):e114221. PubMed ID: 37987160
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Epigenetic balance ensures mechanistic control of MLL amplification and rearrangement.
    Gray ZH; Chakraborty D; Duttweiler RR; Alekbaeva GD; Murphy SE; Chetal K; Ji F; Ferman BI; Honer MA; Wang Z; Myers C; Sun R; Kaniskan HÜ; Toma MM; Bondarenko EA; Santoro JN; Miranda C; Dillingham ME; Tang R; Gozani O; Jin J; Skorski T; Duy C; Lee H; Sadreyev RI; Whetstine JR
    Cell; 2023 Oct; 186(21):4528-4545.e18. PubMed ID: 37788669
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Isocitrate dehydrogenase 1 mutation drives leukemogenesis by PDGFRA activation due to insulator disruption in acute myeloid leukemia (AML).
    Steinhäuser S; Silva P; Lenk L; Beder T; Hartmann A; Hänzelmann S; Fransecky L; Neumann M; Bastian L; Lipinski S; Richter K; Bultmann M; Hübner E; Xia S; Röllig C; Vogiatzi F; Schewe DM; Yumiceba V; Schultz K; Spielmann M; Baldus CD
    Leukemia; 2023 Jan; 37(1):134-142. PubMed ID: 36411356
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Subtype-specific 3D genome alteration in acute myeloid leukaemia.
    Xu J; Song F; Lyu H; Kobayashi M; Zhang B; Zhao Z; Hou Y; Wang X; Luan Y; Jia B; Stasiak L; Wong JH; Wang Q; Jin Q; Jin Q; Fu Y; Yang H; Hardison RC; Dovat S; Platanias LC; Diao Y; Yang Y; Yamada T; Viny AD; Levine RL; Claxton D; Broach JR; Zheng H; Yue F
    Nature; 2022 Nov; 611(7935):387-398. PubMed ID: 36289338
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Tumour-derived small extracellular vesicles suppress CD8+ T cell immune function by inhibiting SLC6A8-mediated creatine import in NPM1-mutated acute myeloid leukaemia.
    Peng M; Ren J; Jing Y; Jiang X; Xiao Q; Huang J; Tao Y; Lei L; Wang X; Yang Z; Yang Z; Zhan Q; Lin C; Jin G; Zhang X; Zhang L
    J Extracell Vesicles; 2021 Nov; 10(13):e12168. PubMed ID: 34807526
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The clinical outcomes and genomic landscapes of acute lymphoblastic leukemia patients with E2A-PBX1: A 10-year retrospective study.
    Zhou B; Chu X; Tian H; Liu T; Liu H; Gao W; Chen S; Hu S; Wu D; Xu Y
    Am J Hematol; 2021 Nov; 96(11):1461-1471. PubMed ID: 34406703
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Assessing acute myeloid leukemia susceptibility in rearrangement-driven patients by DNA breakage at topoisomerase II and CCCTC-binding factor/cohesin binding sites.
    Atkin ND; Raimer HM; Wang Z; Zang C; Wang YH
    Genes Chromosomes Cancer; 2021 Dec; 60(12):808-821. PubMed ID: 34405474
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Disruption of ctcf Boundary at HOXA Locus Promote BET Inhibitors' Therapeutic Sensitivity in Acute Myeloid leukemia.
    Zha J; Lai Q; Deng M; Shi P; Zhao H; Chen Q; Wu H; Xu B
    Stem Cell Rev Rep; 2020 Dec; 16(6):1280-1291. PubMed ID: 33057942
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Determinants and role of chromatin organization in acute leukemia.
    Fang C; Rao S; Crispino JD; Ntziachristos P
    Leukemia; 2020 Oct; 34(10):2561-2575. PubMed ID: 32690881
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. ctcf-mediated genome organization and leukemogenesis.
    Qiu Y; Huang S
    Leukemia; 2020 Sep; 34(9):2295-2304. PubMed ID: 32518417
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Characterization of chromosome organization in the differentiation of acute myeloid leukemia cells by all-trans retinoic acid.
    Hu Y; Zhao H; Zhao Y; Zheng J; Guo Y; Ma J
    Life Sci; 2020 May; 249():117479. PubMed ID: 32119959
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data.
    Fernández-Navarro P; López-Nieva P; Piñeiro-Yañez E; Carreño-Tarragona G; Martinez-López J; Sánchez Pérez R; Aroca Á; Al-Shahrour F; Cobos-Fernández MÁ; Fernández-Piqueras J
    BMC Cancer; 2019 Oct; 19(1):1005. PubMed ID: 31655559
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Broken by the Cut: A Journey into the Role of Topoisomerase II in DNA Fragility.
    Atkin ND; Raimer HM; Wang YH
    Genes (Basel); 2019 Oct; 10(10):. PubMed ID: 31614754
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia.
    Chung W; Kelly AD; Kropf P; Fung H; Jelinek J; Su XY; Roboz GJ; Kantarjian HM; Azab M; Issa JJ
    Clin Epigenetics; 2019 Jul; 11(1):106. PubMed ID: 31331399
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Increased methylation upstream of the MEG3 promotor is observed in acute myeloid leukemia patients with better overall survival.
    Sellers ZP; Bolkun L; Kloczko J; Wojtaszewska ML; Lewandowski K; Moniuszko M; Ratajczak MZ; Schneider G
    Clin Epigenetics; 2019 Mar; 11(1):50. PubMed ID: 30876483
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Lymphocyte-Specific Chromatin Accessibility Pre-determines Glucocorticoid Resistance in Acute Lymphoblastic leukemia.
    Jing D; Huang Y; Liu X; Sia KCS; Zhang JC; Tai X; Wang M; Toscan CE; McCalmont H; Evans K; Mayoh C; Poulos RC; Span M; Mi J; Zhang C; Wong JWH; Beck D; Pimanda JE; Lock RB
    Cancer Cell; 2018 Dec; 34(6):906-921.e8. PubMed ID: 30537513
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. PARP1 Stabilizes ctcf Binding and Chromatin Structure To Maintain Epstein-Barr Virus Latency Type.
    Lupey-Green LN; Caruso LB; Madzo J; Martin KA; Tan Y; Hulse M; Tempera I
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976663
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. ctcf boundary remodels chromatin domain and drives aberrant
    Luo H; Wang F; Zha J; Li H; Yan B; Du Q; Yang F; Sobh A; Vulpe C; Drusbosky L; Cogle C; Chepelev I; Xu B; Nimer SD; Licht J; Qiu Y; Chen B; Xu M; Huang S
    Blood; 2018 Aug; 132(8):837-848. PubMed ID: 29760161
    [No Abstract]    [Full Text] [Related]  

  • 19. Mutational Landscape of Pediatric Acute Lymphoblastic leukemia.
    Ding LW; Sun QY; Tan KT; Chien W; Mayakonda A; Yeoh AEJ; Kawamata N; Nagata Y; Xiao JF; Loh XY; Lin DC; Garg M; Jiang YY; Xu L; Lim SL; Liu LZ; Madan V; Sanada M; Fernández LT; Hema Preethi SS; Lill M; Kantarjian HM; Kornblau SM; Miyano S; Liang DC; Ogawa S; Shih LY; Yang H; Koeffler HP
    Cancer Res; 2017 Jan; 77(2):390-400. PubMed ID: 27872090
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Molecular and Cellular Mechanisms of Myelodysplastic Syndrome: Implications on Targeted Therapy.
    Gill H; Leung AY; Kwong YL
    Int J Mol Sci; 2016 Mar; 17(4):440. PubMed ID: 27023522
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.